Trials / Completed
CompletedNCT03245372
Goal Directed Therapy Versus Standard Care in Lung Resection Surgery (GDT-thorax Study).
Goal Directed Therapy Versus Standard Care in Lung Resection Surgery, a Randomized, Controlled Trial (GDT-thorax Study).
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary aim of this study is to quantify and compare the hemodynamic control of cardiac index in patients who receive either goal-directed therapy or standard hemodynamic management in lung resection surgery
Detailed description
The investigators hypothesize that the percentage of the intraoperative time in which the cardiac index is equal or superior to 2.2 l/min/m2 is higher in goal directed therapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Standard care | Heart rate 60-100 beats per minute, mean arterial pressure 65 mm Hg, serum lactate 2 mmol/L, oxygen saturation 95 % (90 % during one lung ventilation). |
| PROCEDURE | Goal directed therapy | The hemodynamic algorithm will be based on systolic volume index and fluid challenges. FloTrac sensor (this sensor connects to any existing arterial catheter and provides advanced hemodynamic parameters through pulse contour analysis) and EV1000 clinical platform (clinical platform from Edwards Lifesciences that provides advanced hemodynamic monitoring) will be used to calculate cardiac index and systolic volume index. |
Timeline
- Start date
- 2017-10-10
- Primary completion
- 2018-03-23
- Completion
- 2018-09-30
- First posted
- 2017-08-10
- Last updated
- 2021-10-20
- Results posted
- 2021-10-20
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03245372. Inclusion in this directory is not an endorsement.